UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000026399
Receipt No. R000030332
Scientific Title Survey on integrative medicine utilization of Korean general people
Date of disclosure of the study information 2017/03/06
Last modified on 2020/08/02 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments

Basic information
Public title Survey on integrative medicine utilization of Korean general people
Acronym Survey on integrative medicine utilization in Korea
Scientific Title Survey on integrative medicine utilization of Korean general people
Scientific Title:Acronym Survey on integrative medicine utilization in Korea
Region
Asia(except Japan)

Condition
Condition General population
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To clarify the current state of integrated medical care in Korean people
Basic objectives2 Others
Basic objectives -Others utilization study
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Actual utilization
Key secondary outcomes

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Participants should be able to move cursors to read the screen freely.
Key exclusion criteria None
Target sample size 1600

Research contact person
Name of lead principal investigator
1st name Ichiro
Middle name
Last name Arai
Organization Nihon Pharmaceutical University
Division name Kampo Pharmaceutical Sciences
Zip code 362-0806
Address 10281, Komuro, Ina, Kitaadachi, Saitama
TEL 048-721-1155
Email ichiro.arai@nichiyaku.ac.jp

Public contact
Name of contact person
1st name Ichiro
Middle name
Last name Arai
Organization Nihon Pharmaceutical University
Division name Kampo Pharmaceutical Sciences
Zip code 362-0806
Address 10281, Komuro, Ina, Kitaadachi, Saitama
TEL 048-721-1155
Homepage URL
Email ichiro.arai@nichiyaku.ac.jp

Sponsor
Institute Devision of Kampo Pharmaceutical Sciences, Nihon Pharmaceutical University
Institute
Department

Funding Source
Organization AMED
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor Korea Instituate of Orientak Medicine
Name of secondary funder(s)

IRB Contact (For public release)
Organization Ethics Committee, Nihon Pharmaceutical University
Address 10281, Komuro, Ina, Kitaadachi, Saitama, Japan
Tel 048-721-1155
Email i-arai@nichiyaku.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 03 Month 06 Day

Related information
URL releasing protocol https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-018-2294-6
Publication of results Published

Result
URL related to results and publications https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-018-2294-6
Number of participants that the trial has enrolled 1668
Results 
An Internet survey on CAM was conducted for Koreans. In the past year, 67.9% were treated by doctors, 20.7% were treated by Korean Medical doctors, and 14.2% were not treated by anyone. In the CAMs received by doctors' prescriptions and advice, the ratio of Korean traditional medicine such as acupuncture and Korean medicine and health foods was high, and the use of other CAMs was low.
Results date posted
2020 Year 08 Month 02 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics 
General People in Korea
Participant flow 
We collected 200 Korean from a tie-ups company of Anterio has over 500,000 panels.
Adverse events 
none
Outcome measures 
Korean version of International Questionnaire to measure use of CAM
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 01 Month 04 Day
Date of IRB
2017 Year 02 Month 21 Day
Anticipated trial start date
2017 Year 02 Month 24 Day
Last follow-up date
2017 Year 03 Month 10 Day
Date of closure to data entry
2017 Year 03 Month 10 Day
Date trial data considered complete
2017 Year 03 Month 10 Day
Date analysis concluded
2017 Year 03 Month 10 Day

Other
Other related information Internet survey

Management information
Registered date
2017 Year 03 Month 04 Day
Last modified on
2020 Year 08 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030332